110 related articles for article (PubMed ID: 28905625)
1. Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression.
Yohn SE; Gorka D; Mistry A; Collins S; Qian E; Correa M; Manchanda A; Bogner RH; Salamone JD
J Nat Prod; 2017 Oct; 80(10):2839-2844. PubMed ID: 28905625
[TBL] [Abstract][Full Text] [Related]
2. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
[TBL] [Abstract][Full Text] [Related]
3. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
[TBL] [Abstract][Full Text] [Related]
4. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD
PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131
[TBL] [Abstract][Full Text] [Related]
5. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
[TBL] [Abstract][Full Text] [Related]
6. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
Contreras-Mora H; Rowland MA; Yohn SE; Correa M; Salamone JD
Pharmacol Biochem Behav; 2018 Mar; 166():13-20. PubMed ID: 29309800
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
[TBL] [Abstract][Full Text] [Related]
8. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.
Yohn SE; Thompson C; Randall PA; Lee CA; Müller CE; Baqi Y; Correa M; Salamone JD
Psychopharmacology (Berl); 2015 Apr; 232(7):1313-23. PubMed ID: 25323625
[TBL] [Abstract][Full Text] [Related]
9. Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.
Yohn SE; Lopez-Cruz L; Hutson PH; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Mar; 233(6):949-60. PubMed ID: 26694811
[TBL] [Abstract][Full Text] [Related]
10. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions.
Yohn SE; Reynolds S; Tripodi G; Correa M; Salamone JD
Behav Brain Res; 2018 Apr; 342():27-34. PubMed ID: 29292157
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040.
Yohn SE; Gogoj A; Haque A; Lopez-Cruz L; Haley A; Huxley P; Baskin P; Correa M; Salamone JD
Pharmacol Biochem Behav; 2016 Sep; 148():84-91. PubMed ID: 27296079
[No Abstract] [Full Text] [Related]
12. The Novel Atypical Dopamine Uptake Inhibitor
Rotolo RA; Dragacevic V; Kalaba P; Urban E; Zehl M; Roller A; Wackerlig J; Langer T; Pistis M; De Luca MA; Caria F; Schwartz R; Presby RE; Yang JH; Samels S; Correa M; Lubec G; Salamone JD
Front Pharmacol; 2019; 10():682. PubMed ID: 31316379
[TBL] [Abstract][Full Text] [Related]
13. Effects of the dopamine depleting agent tetrabenazine on detailed temporal parameters of effort-related choice responding.
Ren N; Carratala-Ros C; Ecevitoglu A; Rotolo RA; Edelstein GA; Presby RE; Stevenson IH; Chrobak JJ; Salamone JD
J Exp Anal Behav; 2022 May; 117(3):331-345. PubMed ID: 35344599
[TBL] [Abstract][Full Text] [Related]
14. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
[TBL] [Abstract][Full Text] [Related]
15. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists.
Yohn SE; Santerre JL; Nunes EJ; Kozak R; Podurgiel SJ; Correa M; Salamone JD
Pharmacol Biochem Behav; 2015 Aug; 135():217-26. PubMed ID: 26022661
[TBL] [Abstract][Full Text] [Related]
16. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.
Nunes EJ; Randall PA; Estrada A; Epling B; Hart EE; Lee CA; Baqi Y; Müller CE; Correa M; Salamone JD
Psychopharmacology (Berl); 2014 Feb; 231(4):727-36. PubMed ID: 24136220
[TBL] [Abstract][Full Text] [Related]
17. Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.
Pardo M; López-Cruz L; San Miguel N; Salamone JD; Correa M
Psychopharmacology (Berl); 2015 Jul; 232(13):2377-91. PubMed ID: 25647696
[TBL] [Abstract][Full Text] [Related]
18. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.
Yohn SE; Arif Y; Haley A; Tripodi G; Baqi Y; Müller CE; Miguel NS; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3575-86. PubMed ID: 27497935
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: Suppression of high effort activity by the serotonin transport inhibitor fluoxetine.
Presby RE; Rotolo RA; Hurley EM; Ferrigno SM; Murphy CE; McMullen HP; Desai PA; Zorda EM; Kuperwasser FB; Carratala-Ros C; Correa M; Salamone JD
Pharmacol Biochem Behav; 2021 Mar; 202():173115. PubMed ID: 33493546
[TBL] [Abstract][Full Text] [Related]
20. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
